Long-Term Debt: Ocugen Inc (OCGN)

Brandmark of Ocugen Inc (OCGN)

Ocugen, Inc. (OCGN) specializes in developing innovative drugs for the treatment of vision pathologies. This chart on GURU.Markets visualizes the results of partnerships with global scientific centers and acquisitions of DNA technologies. The current indicator is 0.00. Financial stability is maintained through equity offerings to cover R&D expenses. High margins are achieved through patent protection of unique therapy methods.

OCGN Ocugen, Inc. Company Long-Term Liabilities (07/04/2022 - 10/31/2026)

Ocugen Corp (OCGN) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price ocugen.com|OCGN - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Ocugen|OCGN - Enterprise Value
- book capitalization data:
Accounting Value per Share Ocugen|OCGN - Company Net Assets|Market Capitalization to Book Value Ratio ocugen.com|OCGN - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Ratio Ocugen, Inc.|OCGN - Long-Term Debt to Capital|Current Liabilities to Capital Ocugen Pharma|OCGN - Company Debts|Debt to Book Value Ratio Ocugen|OCGN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Ocugen|Interim Coverage Ratio ocugen.com
- earnings and multiples data:
OCGN - Company Net Income
Analysis of all company metrics:ocugen.com - OCGN
Core merchandise of Ocugen

The monopoly potential of gene therapy for blindness requires massive capital expenditures prior to the commercialization of drugs. This indicator aggregates all liabilities and bonds with maturities exceeding one year, determining the cost of long-term R&D financing. An increase in this metric under tight monetary policy raises debt service costs. By analyzing the trend of the business's long-term borrowed capital, an investor assesses the sustainability of the Ocugen, Inc. (OCGN) financial model.

Competitor analysis for Ocugen, Inc.

Company Long-Term Debts Tempus Labs TEM|QGEN - Company Long-Term Debt|Long-Term Debt Ionis Pharmaceuticals, Inc.|RGEN: Company Long-Term Debts|Company Long-Term Liabilities Avidity Corp|Company Long-Term Liabilities CRSP|Company Long-Term Debts genedx.com|Company Long-Term Debts RARE|Beam Therapeutics Inc (BEAM) - Long-Term Indebtedness|Company Long-Term Debts SRPT (Sarepta Therapeutics Inc)|Twist Bioscience Corp (TWST) - Long-Term Debt|TXG - Company Long-Term Debt|NTLA (intelliatx.com) - Company Long-Term Indebtedness|STOK (Stoke Therapeutics, Inc.) - Company Long-Term Liabilities|BioLife Solutions Inc - Company Long-Term Loans and Borrowings|WVE (Wave Life Sciences Corp) - Company Long-Term Debts|Maze Therapeutics Corp (MAZE) - Long-Term Debt Volume|Company Long-Term Debt Sionna Therapeutics Inc (SION)|primemedicine.com - Company Long-Term Indebtedness|Company Long-Term Debts TSHA (Taysha Gene Therapies, Inc.)|QURE - Company Long-Term Liabilities|MGTX: Company Long-Term Liabilities|Long-Term Debt Volume REGENXBIO Corp RGNX|Solid Biosciences Inc. (SLDB) - Company Long-Term Debt|Long-Term Debt pacb.com (PACB)|BNTC (Benitec Biopharma) - Company Long-Term Debts|Company Long-Term Liabilities Design Therapeutics Inc (DSGN)|Company Long-Term Debts RCKT|4D Molecular Corp (FDMT) - Long-Term Indebtedness|Company Long-Term Debt Lexeo Therapeutics, Inc. LXEO|KRRO: Company Long-Term Indebtedness|Editas Medicine - Company Long-Term Debts|SLN (Silence Therapeutics PLC) - Company Long-Term Indebtedness|proqr.com (PRQR) - Company Long-Term Debt|Company Long-Term Indebtedness CDXS|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Company Long-Term Debts Nautilus Biotechnology Inc|Company Long-Term Debt Metagenomi (MGX)|DTIL - Long-Term Debt|Company Long-Term Debts GBIO (Generation Bio)|BOLD - Company Long-Term Liabilities|XCUR: Company Long-Term Liabilities|IMNN - Company Long-Term Debts|PHIO: Company Long-Term Debts|Long-Term Indebtedness Mustang Bio MBIO|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Long-Term Debt Bionano BNGO|Company Long-Term Debt Applied DNA Sciences (APDN)|bluebirdbio.com - Company Long-Term Indebtedness|ImmunoPrecise Antibodies Ltd. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings OMGA|Singular Genomics Systems Inc - Company Long-Term Debts|Long-Term Debt Volume Regulus RGLS|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Company Long-Term Indebtedness TBIO|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Unity Biotechnology Inc. (UBX)